Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Applying LC-MS/MS techniques to the development of biologics

4 May 2018
General interest

PPD® Laboratories’ Unique Approach to Biologics
For three decades, PPD Laboratories has been developing and validating bioanalytical assays for all
phases of pharmaceutical development across a wide variety

Please click here to download PPD Laboratories tech sheet on applying LC-MS/MS techniques to the development of biologics.

 

Top content

  • What does 2026 hold for bioanalysis?
  • New blood testing technology for Alzheimer’s Bio-Hermes-002 study
  • Bioanalysis and Bioanalysis Zone unveil the 6th edition of The Bioanalysis Glossary 

Related tags

LC-MS LC–MS/MS pharmaceuticals PPD quantification
Previous article Next article

Related articles

9 JUN 2015 CHROMATOGRAPHY
9th WRIB LC-MS poster award winner interview
13 APR 2015 DRUG DEVELOPMENT
Bioanalysis of antibody–drug conjugates: American Association of Pharmaceutical Scientists antibody–drug conjugate working group position paper
11 JAN 2018 NEWS
Publish with us!
8 JUL 2015 CHROMATOGRAPHY
Microspray and microflow LC–MS/MS: the perfect fit for bioanalysis
8 NOV 2021 ASK THE EXPERTS
6. How have current regulations affected the development of oligonucleotide therapeutics?
30 MAR 2023 ADVANCED THERAPIES
Tracking the therapy: the roles of bioanalysis in AAV-dosed gene therapy trials
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone